Global Companion Animal Vaccine Market to reach USD 13.0 billion by 2027.

Global Companion Animal Vaccine Market Size study, by Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Technologies), by Animal Type (Dogs, Cats, Other Animal Types ), and Regional Forecasts 2021-2027
Product Code:  HALDAT_55153901
 Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1.	Companion Animal Vaccine Market , by Region, 2019-2027 (USD Billion)
1.2.2.	Companion Animal Vaccine Market , by   Technology, 2019-2027 (USD Billion)
1.2.3.	Companion Animal Vaccine Market , by   Animal Type, 2019-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Companion Animal Vaccine Market  Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Companion Animal Vaccine Market  Dynamics	
3.1.	Companion Animal Vaccine Market Impact Analysis (2019-2027)
3.1.1.	Market Drivers
3.1.1.1.	Rising adoption of companion animals, such as dogs and cats     
3.1.1.2.	Increasing cases of zoonotic diseases   
3.1.2.	Market Restraint
3.1.2.1.	High cost of vaccine development and regulatory concern      
3.1.3.	Market Opportunities
3.1.3.1.	Technological advancements        
Chapter 4.	Global Companion Animal Vaccine Market  Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Companion Animal Vaccine Market , by   Technology
5.1.	Market Snapshot 
5.2.	Global Companion Animal Vaccine Market  by  Technology , Performance - Potential Analysis
5.3.	Global Companion Animal Vaccine Market  Estimates & Forecasts by  Technology  2018-2027 (USD Billion)
5.4.	Companion Animal Vaccine Market , Sub Segment Analysis
5.4.1.	Live Attenuated Vaccines
5.4.2.	Inactivated Vaccines
5.4.3.	Toxoid Vaccines
5.4.4.	Recombinant Vaccines
5.4.5.	Other Technologies  
Chapter 6.	Global Companion Animal Vaccine Market , by   Animal Type
6.1.	Market Snapshot 
6.2.	Global Companion Animal Vaccine Market  by  Animal Type, Performance - Potential Analysis
6.3.	Global Companion Animal Vaccine Market  Estimates & Forecasts by   Animal Type    2018-2027 (USD Billion)
6.4.	Companion Animal Vaccine Market , Sub Segment Analysis
6.4.1.	Dogs
6.4.2.	Cats
6.4.3.	Other Animal Types  
Chapter 7.	Global Companion Animal Vaccine Market , Regional Analysis
7.1.	Companion Animal Vaccine Market , Regional Market Snapshot 
7.2.	North America Companion Animal Vaccine Market  
7.2.1.	U.S. Companion Animal Vaccine Market 
7.2.1.1.	Technology breakdown estimates & forecasts, 2018-2027
7.2.1.2.	Animal Type breakdown estimates & forecasts, 2018-2027
7.2.2.	Canada Companion Animal Vaccine Market 
7.3.	Europe Companion Animal Vaccine Market  Snapshot
7.3.1.	U.K. Companion Animal Vaccine Market  
7.3.2.	Germany Companion Animal Vaccine Market 
7.3.3.	France Companion Animal Vaccine Market 
7.3.4.	Spain Companion Animal Vaccine Market 
7.3.5.	Italy Companion Animal Vaccine Market 
7.3.6.	Rest of Europe Companion Animal Vaccine Market 
7.4.	Asia-Pacific Companion Animal Vaccine Market  Snapshot
7.4.1.	China Companion Animal Vaccine Market  
7.4.2.	India Companion Animal Vaccine Market  
7.4.3.	Japan Companion Animal Vaccine Market 
7.4.4.	Australia Companion Animal Vaccine Market 
7.4.5.	South Korea Companion Animal Vaccine Market 
7.4.6.	Rest of Asia Pacific Companion Animal Vaccine Market 
7.5.	Latin America Companion Animal Vaccine Market  Snapshot
7.5.1.	Brazil Companion Animal Vaccine Market 
7.5.2.	Mexico Companion Animal Vaccine Market 
7.6.	Rest of The World Companion Animal Vaccine Market 
Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	Elanco Animal Health Incorporated                 
8.2.1.1.	Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Technology Summary
8.2.1.5.	Recent Developments
8.2.2.	Boehringer Ingelheim GmbH      
8.2.3.	Brilliant Bio Pharma                     
8.2.4.	Merck & Co. Inc.                       
8.2.5.	Virbac                        
8.2.6.	Zoetis Inc.                         
8.2.7.	Indian Immunologicals Ltd                        
8.2.8.	  Bioveta AS                        
8.2.9.	Vetoquinol S.A.        
8.2.10.	 Merial (Sanofi)         

Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Companion Animal Vaccine Market is valued at approximately USD 8.0 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.2 % over the forecast period 2021-2027. The rising adoption of domestic animals such as dogs and cats, as well as the rising reports of zoonotic diseases, are driving the global companion animal vaccines industry. Companion animals are currently among the most common domesticated animals, with dogs, cats, and horses dominating the market. For instance, according to the annual report of the European Pet Food Industry Association (FEDIAF) for 2020, dogs and cats are the most common pets in Europe. Furthermore, at least one domestic animal is owned by an estimated 85 million European households. During the forecast period, the trend is estimated to continue. In addition, The COVID-19 pandemic is projected to have a major effect on the industry under consideration. In July 2020, the Centers for Disease Control and Prevention issued detailed and precautionary recommendations to veterinary practitioners for the care of domestic animals during the COVID-19 pandemic. For instance, Veterinary hospitals and clinics should prioritise immediate and emergency visits and services, according to several health bodies, including the Centers for Disease Control and Prevention. This effort by national bodies is intended to reduce veterinary healthcare management’s reliance on and use of diagnostic equipment. In addition, several veterinary laboratories are currently engaged in COVID-19 research in humans, according to the OIE: World Organization for Animal Welfare, in order to address the global lack of healthcare facilities and COVID-19 testing laboratories. However, high storage cost of vaccines may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Companion Animal Vaccine Market is considered for the key regions such as Europe, North America, Asia Pacific, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to growing pet population, along with an increase in spending on pet care. Whereas Asia Pacific is also estimated to show the highest growth rate over the forecast period 2021-2027. Factors such as rising pet adoption, expansion of key vaccine players, the product availability, and investments in manufacturing facilities in various Asia Pacific countries, particularly in India, China, and Thailand, are driving the market’s growth.

Major market player included in this report are:

Elanco Animal Health Incorporated
Boehringer Ingelheim GmbH
Brilliant Bio Pharma
Merck & Co. Inc.
Virbac
Zoetis Inc.
Indian Immunologicals Ltd
Bioveta AS
Vetoquinol S.A.
Merial (Sanofi)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Animal Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Technologies
By Animal Type:
Dogs
Cats
Other Animal Types
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.

Target Audience of the Global Companion Animal Vaccine Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…